| Identification | Back Directory | [Name]
(S)-N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide | [CAS]
841205-47-8 | [Synonyms]
GTx-024
MK-2886
Ostarine
EnobosarM
MK2866（S-22）
Ostarine, >=99%
Ostarine MK-286
Qstarine/MK-2866
Ostarine,GTx-024
Ostarine(MK2286)
ENOBOSAM(MK2866)
MK-2866 (GTx-024)
Enobosarm MK-2866
OSTARINE 841205-47-8
enobosarm (ostarine )
MK2866（GTx-024，Ostarine）
Ostarine (GTx-024,MK-2866)
ENOBOSAM(MK2866) (Ostarine)
MK677,MK2866,CAS841205-47-8
OSTARINE(MK-2866) 99% Purity
99% Purity OSTARINE(MK-2866)
High Quality OSTARINE(MK-2866)
Ostarine
NOT FOR SALE-PATENTED
OSTARINE(MK-2866) with High quality
Mk 2866 Ostarine Sarms Powder Mk2866
OSTARINE(MK-2866) Pharmaceutical Grade
OSTARINE;MK-2866;GTX-024;MK2866;GTX024;MK 2866;GTX 024
OSTARINE;MK-2866;GTX-024;MK2866;GTX024;MK 2866;GTX 024;ENOBOSARM
CAS 841205-47-8/1202044-20-9 Pharmaceutical Raw Materials Ostarine MK-2866 Enobosarm
(S)-N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide
(S)-3-(4-Cyanophenoxy)-N-(4-cyano-3-(trifluoromethyl)phenyl)-2-hydroxy-2-methylpropanamide
(S)-3-(4-Cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropionamide
PropanaMide, 3-(4-cyanophenoxy)-N-[4-cyano-3-(trifluoroMethyl)phenyl]-2-hydroxy-2-Methyl-, (2S)-
(S)-N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide USP/EP/BP
Qstarine,MK-2866,(S)-N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide
(S)-N-(4-Cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide MK-2866, Ostarine | [EINECS(EC#)]
803-892-7 | [Molecular Formula]
C19H14F3N3O3 | [MDL Number]
MFCD16877675 | [MOL File]
841205-47-8.mol | [Molecular Weight]
389.33 |
| Questions And Answer | Back Directory | [description]
Ostarine, also known as MK-2866, is a selective androgen receptor modulator (SARM) that has been shown to be effective in helping people lose weight and build muscle mass. Ostarine works by binding to the androgen receptors in the body, which can help reduce body fat and increase muscle mass. It is non-toxic and has few side effects, making it a safe choice for those looking for an edge in the gym. | [Uses]
(2S)-3-(4-Cyanophenoxy-2,3,5,6-d4)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide is a metabolites of selective androgen receptor modulators (SARM). | [Application]
Ostarine is a non-steroidal agent with anabolic activity. Selective androgen receptor modulator (SARM) GTx-024 is designed to work like testosterone, thus promoting and/or maintaining libido, fertility, prostate growth, and muscle growth and strength. Mimicking testosterone's action, this agent may increase lean body mass, thereby ameliorating muscle wasting in the hypermetabolic state of cancer cachexia.
Ostarine has been used in trials studying the treatment of Stress Urinary Incontinence and Triple Negative Breast Cancer. | [Physiological action]
Ostarine is a selective androgen receptor modulator (SARM) with Ki of 3.8 nM. Plasma concentration of ostarine declines in a biexponential manner after intravenous administration with terminal half-live of 6.0 hours. In vivo, ostarine significantly stimulates the growth of prostate, seminal vesicles, and levator ani muscle in castrated rats. Ostarine restores the weights of the prostate to 39.2%, of that observed in the intact control. The weight of seminal vesicle is also restored by ostarine to 78.8%, respectively, of that observed in the intact control. Ostarine stimulates the growth of levator ani muscle to a greater extent than androgenic organs, to 141.9%. |
| Chemical Properties | Back Directory | [Boiling point ]
632.3±55.0 °C(Predicted) | [density ]
1.41±0.1 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
DMSO:70.0(Max Conc. mg/mL);179.8(Max Conc. mM) | [pka]
12.13±0.29(Predicted) | [InChI]
InChI=1S/C19H14F3N3O3/c1-18(27,11-28-15-6-2-12(9-23)3-7-15)17(26)25-14-5-4-13(10-24)16(8-14)19(20,21)22/h2-8,27H,11H2,1H3,(H,25,26)/t18-/m0/s1 | [InChIKey]
JNGVJMBLXIUVRD-SFHVURJKSA-N | [SMILES]
C(NC1=CC=C(C#N)C(C(F)(F)F)=C1)(=O)[C@](O)(C)COC1=CC=C(C#N)C=C1 |
| Hazard Information | Back Directory | [Origin]
Ostarine is an orally bioavailable, nonsteroidal SARM that was developed by Gtx, Inc. in the late 1990s primarily for the treatment of muscle wasting and osteoporosis.
| [Side effects]
Common low-grade side effects included headache, nausea, fatigue, and back pain. Other observed effects were transient elevation in the alanine transaminase (ALT), reductions in high density lipoprotein (HDL), blood glucose, insulin, and insulin resistance. The side effects of decreased testosterone include reduced sex drive, infertility, muscle weakness, loss of bone density, weight gain accompanied by increased body fat, insomnia, and depression. | [storage]
Store at -20°C |
|
|